| Literature DB >> 32079289 |
Anas Najjar1, Abderrahman Najjar2, Rafik Karaman1.
Abstract
BACKGROUND: The design and development of prodrugs is the most common and effective strategy to overcome pharmacokinetic and pharmacodynamic drawbacks of active drugs. A respected number of prodrugs have been reached the drugs market throughout history and the recent years have witnessed a significant increase in the use of prodrugs as a replacement of their parent drugs for an efficient treatment of various ailment.Entities:
Keywords: ACT-281959; ANAVEX 2-73; baloxavir marboxil; clinical trial; evofosfamide; fostemsavir; ixazomib; pretomanid; prodrug; selexipag
Year: 2020 PMID: 32079289 DOI: 10.3390/molecules25040884
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411